Background: Though uncommon, primary movement disorders can occur in pregnancy, the most common being restless legs syndrome and chorea gravidarum [1]. New onset dystonia in pregnancy has been reported four times previously with a resolution of symptoms within six months of delivery [2345]. Exacerbation of pre-existing movement disorders and the onset of de novo movement disorders during pregnancy support the hypothesis that female sex hormones play an important role in the regulation of basal ganglia circuitry.
Case Report: Here we describe a case of new-onset cervical dystonia during pregnancy with persistence of symptoms after delivery.
Discussion: The phenotypic overlap between this case and previously reported cases further establishes dystonia gravidarum as a distinct clinical entity.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783953 | PMC |
http://dx.doi.org/10.5334/tohm.734 | DOI Listing |
Clin Nutr ESPEN
November 2024
Yoda Diagnostics Pvt Ltd, 6-3-862/A, Lal Bungalow add on, Ameerpet, Hyderabad, India. Electronic address:
Mov Disord Clin Pract
November 2024
Department of Neurology, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, USA.
J Addict Med
November 2024
From the University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC (ESK); Addiction Medical Services of Wisconsin, Onalaska, WI (CWS); Health Sciences Library, University of North Carolina at Chapel Hill, Chapel Hill, NC (JLC); and Horizons Division and Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC, and Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, School of Medicine, Johns Hopkins University, Baltimore, MD (HEJ).
Objectives: Inhalants are often used for their psychoactive effects, producing feelings of euphoria. Inhalant and solvent use is a serious public health concern, yet little is known about their effects on perinatal, fetal, and child outcomes. The aim of our review is to evaluate the impact of inhalant use by pregnant people on maternal, fetal, neonatal, and early childhood outcomes.
View Article and Find Full Text PDFOrphanet J Rare Dis
October 2024
Genomenon, Inc, 206 E. Huron St. Suite 114, Ann Arbor, MI, 48109, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!